2,4-thiazolidinedione has been researched along with Hypersensitivity in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Momoi, A | 1 |
| Murao, K | 1 |
| Imachi, H | 1 |
| Sayo, Y | 1 |
| Nakamura, H | 1 |
| Hosokawa, H | 1 |
| Sato, M | 1 |
| Fujita, J | 1 |
| Okada, H | 1 |
| Ishida, T | 1 |
| Takahara, J | 1 |
1 other study available for 2,4-thiazolidinedione and Hypersensitivity
| Article | Year |
|---|---|
Thiazolidinedione inhibits production of RANTES in a cytokine-treated human lung epithelial cell line.
Topics: Cell Line; Chemokine CCL5; Chemotaxis, Leukocyte; Dexamethasone; Eosinophils; Epithelial Cells; Gene | 1999 |